1-6 of 6
Sandy W. Wong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma

Clinical Trials & Observations
Kevin R. Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2207–2216.
https://doi.org/10.1182/bloodadvances.2023012066
Published: 2024
Includes: Supplemental data
Journal Articles

Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies

Mazie Tsang, Kara Bischoff, Kelly L. Schoenbeck, Kim Berry, David O’Riordan, Bita Fakhri, Sandy W. Wong, Nina Shah, Rebecca Olin, Charalambos Andreadis, Jules Vieaux, Eve Cohen, Nancy Shepard Lopez, Gabriel N. Mannis, Michael Rabow
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3146–3149.
https://doi.org/10.1182/bloodadvances.2022009039
Published: 2023
Journal Articles

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy

Swetha Kambhampati, Ying Sheng, Chiung-Yu Huang, Sophia Bylsma, Mimi Lo, Vanessa Kennedy, Kelsey Natsuhara, Thomas Martin, Jeffrey Wolf, Nina Shah, Sandy W. Wong
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2045–2054.
https://doi.org/10.1182/bloodadvances.2020004079
Published: 2022
Includes: Supplemental data
Journal Articles

Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

Vanessa E. Kennedy, Christopher Wong, Chiung-Yu Huang, Swetha Kambhampati, Jeffrey Wolf, Thomas G. Martin, Nina Shah, Sandy W. Wong
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5344–5348.
https://doi.org/10.1182/bloodadvances.2021005020
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma

Clinical Trials & Observations
Joaquin Martinez-Lopez, Sandy W. Wong, Nina Shah, Natasha Bahri, Kaili Zhou, Ying Sheng, Chiung-Yu Huang, Thomas Martin, Jeffrey Wolf
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3295–3301.
https://doi.org/10.1182/bloodadvances.2020002037
Published: 2020
Journal Articles

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong, Thomas G. Martin, III, Jeffrey L. Wolf, Kole T. Roybal, Andreas Pahl, Jack Taunton, Arun P. Wiita, Martin Kampmann
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2899–2911.
https://doi.org/10.1182/bloodadvances.2019001346
Published: 2020
Includes: Supplemental data